Onconetix names David White as CEO, adds Sammy Dorf to board

Go back to Onconetix names David White as CEO, adds Sammy Dorf to board

Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors

March 31, 2026 8:30 AM EDT

Experienced Leadership Team Positioned to Execute Pending Transformative Acquisition of Realbotix LLC and Drive Long-Term Shareholder Value

CINCINNATI, Ohio, March 31, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (Onconetix or the Company) today announced the appointment of David White as Chief Executive Officer, effective March 18, 2026, and the appointment of Sammy Dorf as a member of the Companys Board of Directors and the Audit Committee, effective March 19, 2026. Karina Fedasz, the Companys outgoing Interim Chief Executive Officer, will continue to serve as its Interim Chief Financial Officer. These appointments reflect the Companys... More